Synergizing Regeneration and Pharmacology: Metformin-Loaded MSC Exosomes as a Biologically Intelligent Strategy for Myocardial Repair
Pages 800-801
https://doi.org/10.30491/hpr.2026.244723
Mostafa Akbariqomi, Reza Heidari
Abstract Despite remarkable advances in reperfusion strategies, antithrombotic therapy, and secondary prevention, myocardial infarction (MI) remains a leading cause of heart failure and cardiovascular mortality worldwide. Among emerging regenerative approaches, exosome engineering has attracted considerable scientific interest. Exosomes are nano-sized extracellular vesicles secreted by nearly all cell types and are now recognized as highly organized mediators of intercellular communication. By transporting microRNAs, proteins, lipids, and signaling molecules, exosomes influence gene expression and cellular behavior in target tissues. We argue that integrating metabolic modulators with engineered exosome delivery platforms represents not merely an incremental innovation but a paradigm shift in post-MI regenerative therapy.







